| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EDWARDS LIFESCIENCES CORP | 1,500,000 | 149,595,000 | 8.16% | ||
| 2 | LABORATORY CORP AMER HLDGS | 1,100,000 | 143,297,000 | 7.82% | ||
| 3 | HOLOGIC INC | 4,000,000 | 138,400,000 | 7.55% | ||
| 4 | AETNA INC NEW | 1,000,000 | 122,130,000 | 6.66% | ||
| 5 | ZIMMER BIOMET HLDGS INC | 1,000,000 | 120,380,000 | 6.57% | ||
| 6 | BIOGEN INC | 475,000 | 114,865,000 | 6.26% | ||
| 7 | QUEST DIAGNOSTICS INC | 1,150,000 | 93,621,000 | 5.11% | ||
| 8 | AKORN INC | 2,100,000 | 59,819,000 | 3.26% | ||
| 9 | BIOMARIN | 750,000 | 58,350,000 | 3.18% | ||
| 10 | MERCK & CO INC | 1,000,000 | 57,610,000 | 3.14% | Call | |
| 11 | HealthSouth Corp | 1,450,000 | 56,289,000 | 3.07% | ||
| 12 | QIAGEN NV | 2,500,000 | 54,525,000 | 2.97% | ||
| 13 | WALGREENS BOOTS ALLIANCE INC | 496,680 | 41,359,000 | 2.26% | ||
| 14 | HILL ROM HLDGS INC | 815,603 | 41,147,000 | 2.24% | ||
| 15 | HUMANA | 214,920 | 38,660,000 | 2.11% | ||
| 16 | ACADIA HEALTHCARE COMPANY IN | 684,220 | 37,906,000 | 2.07% | ||
| 17 | CLOVIS ONCOLOGY INC | 2,650,000 | 36,358,000 | 1.98% | ||
| 18 | THERMO FISHER SCIENTIFIC INC | 233,245 | 34,464,000 | 1.88% | ||
| 19 | ICON PLC | 475,000 | 33,255,000 | 1.81% | ||
| 20 | UNIVERSAL HLTH SVCS INC | 243,490 | 32,652,000 | 1.78% | ||
| 21 | DEXCOM | 396,030 | 31,417,000 | 1.71% | ||
| 22 | PERKINELMER INC | 582,500 | 30,535,000 | 1.67% | ||
| 23 | CORINDUS VASCULAR ROBOTICS I COM | 19,981,655 | 28,574,000 | 1.56% | ||
| 24 | ENVISION HEALTHCARE HLDGS INC | 1,052,160 | 26,693,000 | 1.46% | ||
| 25 | CVS HEALTH CORP | 237,830 | 22,770,000 | 1.24% | ||
| 26 | GILEAD SCIENCES INC | 270,680 | 22,580,000 | 1.23% | ||
| 27 | PRA HEALTH SCIENCES INC | 526,700 | 21,995,000 | 1.20% | ||
| 28 | NEUROCRINE BIOSCIE COM USD0.001 | 450,000 | 20,453,000 | 1.12% | ||
| 29 | HCA HOLDINGS INC | 257,870 | 19,859,000 | 1.08% | ||
| 30 | MERCK & CO INC | 288,150 | 16,600,000 | 0.91% | ||
| 31 | DEXCOM | 200,000 | 15,866,000 | 0.87% | Call | |
| 32 | COLLEGIUM PHARMACEUTICAL INC COM | 1,325,000 | 15,701,000 | 0.86% | ||
| 33 | BRISTOL MYERS SQUIBB CO | 211,940 | 15,588,000 | 0.85% | ||
| 34 | INC Research Holdings Inc | 400,000 | 15,252,000 | 0.83% | ||
| 35 | NEUROCRINE BIOSCIE COM USD0.001 | 310,000 | 14,090,000 | 0.77% | Call | |
| 36 | WATERS CORP | 95,530 | 13,436,000 | 0.73% | ||
| 37 | PACIRA BIOSCIENCES INC | 250,000 | 8,433,000 | 0.46% | ||
| 38 | ARBUTUS BIOPHARMA | 2,258,300 | 7,859,000 | 0.43% | ||
| 39 | SEASPINE HLDGS CORP COM | 623,100 | 6,530,000 | 0.36% | ||
| 40 | RAPTOR PHARMACEUTICAL CORP | 1,051,315 | 5,646,000 | 0.31% | ||
| 41 | NATERA INC | 290,600 | 3,506,000 | 0.19% | ||
| 42 | ALIGN TECHNOLOGY INC | 41,730 | 3,361,000 | 0.18% | ||
| 43 | CONATUS PHARMACEUTICALS INC COM | 1,059,200 | 2,182,000 | 0.12% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001343781-16-000014, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
